Celgene is a Bristol-Myers Squibb company Select CONTINUE for information about Celgene. Select BMS to learn more about Bristol Myers Squibb. CONTINUEBMS Global Offices SEARCH INVESTORS INVESTORS PRESS RELEASE ARCHIVE EVENTS & PRESENTATIONS ARCHIVE ACQUISITION FAQS FOR SHAREHOLDERS Celgene is now part of Bristol Myers Squibb creating a leading biopharma company positioned to address the needs of patients with serious diseases. Read Press Release Acquisition FAQs for Shareholders Bristol Myers Squibb Investor Relations Investors > Investors Press Release Archive Celgene Announces Plans to Transfer Listing of Celgene’s Contingent Value Rights Following Closing of Acquisition by Bristol Myers Squibb Events & Presentations Archive Celgene Corporation Q3 2019 Earnings Acquisition FAQs for Shareholders

SEARCH AUSTRALIA ABOUT PRODUCT INFORMATION RESEARCH & DEVELOPMENT RESPONSIBILITY MEDIA Patients Healthcare Professionals Investors Careers Contact Us Celgene is a Bristol Myers Squibb company. Read Press Release Transparency Payments to Healthcare Professionals. Pipeline Helping people live longer, better, healthier lives. Creating an Innovative Biopharma Leader with Global Reach and Scale Patients Learn about our commitment to and services for patients. Careers Begin your search for opportunities at Celgene today! Responsibility Learn how our business decisions reflect our values. A Decade of Progress in Myeloma, And More to Come GLOBAL OFFICE LOCATIONS HAVE A QUESTION OR CONCERN? CONTACT US ABOUT PRODUCT INFORMATION RESEARCH & DEVELOPMENT RESPONSIBILITY MEDIA PATIENTS HEALTHCARE PROFESSIONALS INVESTORS CAREERS PIPELINE PRIVACY POLICY LEGAL NOTICE SITE MAP COPYRIGHT © 2021 CELGENE CORPORATION A BRISTOL MYERS SQUIBB COMPANY PRIVACY POLICY LEGAL NOTICE Celgene is a Bristol Myers Squibb company Select CONTINUE for information about Celgene. Select BMS to learn more about Bristol Myers Squibb. CONTINUE BMS